HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacology of 5-chloro-7-trifluoromethyl-1,4-dihydro-2,3-quinoxalinedione: a novel systemically active ionotropic glutamate receptor antagonist.

Abstract
5-Chloro-7-trifluoromethyl-1,4-dihydro-2,3-quinoxalinedione (ACEA-1011) has analgesic properties in animal models of tonic pain. To investigate the mechanisms underlying this effect we used electrical recording techniques to characterize the in vitro pharmacology of ACEA-1011 at mammalian glutamate receptors. Two preparations were used: Xenopus oocytes expressing rat brain receptors and cultured rat cortical neurons. Results showed that ACEA-1011 is a competitive antagonist at NMDA receptor glycine sites. Apparent antagonist affinities (Kb values) were 0.4 to 0.8 microM in oocytes and approximately 0.6 microM in neurons. IC50 values for ACEA-1011 against four binary subunit combinations of cloned rat NMDA receptors (NR1A/NR2A, 2B, 2C or 2D) ranged from 0.4 to 8 microM (1 microM glycine). The 20-fold variation in sensitivity was due to a combination of subunit-dependent differences in glycine and antagonist affinities; EC50 values for glycine ranged between 0.08 to 0.8 microM and Kb values for ACEA-1011 between 0.2 to 0.8 microM. In addition, ACEA-1011 inhibited AMPA-preferring non-NMDA receptors by competitive antagonism at glutamate binding sites. Kb values were 4 to 9 microM in oocytes and 9 to 10 microM in neurons. The ED50 for ACEA-1011 in a mouse maximum electroshock-induced seizure model was approximately 12 mg/kg i.v.. Our results indicate that ACEA-1011 is a systemically active broad selectivity ionotropic glutamate receptor antagonist.
AuthorsR M Woodward, J E Huettner, M Tran, J Guastella, J F Keana, E Weber
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 275 Issue 3 Pg. 1209-18 (Dec 1995) ISSN: 0022-3565 [Print] United States
PMID8531083 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Analgesics
  • Anticonvulsants
  • Excitatory Amino Acid Antagonists
  • Quinoxalines
  • RNA, Messenger
  • Receptors, Glutamate
  • ACEA 1011
Topics
  • Analgesics (pharmacology)
  • Animals
  • Anticonvulsants (pharmacology)
  • Brain (drug effects, metabolism, physiology)
  • Cells, Cultured
  • Cloning, Molecular
  • Excitatory Amino Acid Antagonists (pharmacology)
  • Mice
  • Neurons (physiology)
  • Quinoxalines (pharmacology)
  • RNA, Messenger (metabolism)
  • Rats
  • Receptors, Glutamate (metabolism)
  • Seizures (physiopathology, prevention & control)
  • Xenopus laevis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: